News and Events

Find our current Cardiothoracic events and news stories below.

WCM Receives Milestone in Mitral Valve Repair for the 2nd Year

2024 Mitral Valve Award Seals
Weill Cornell's Department of Cardiothoracic Surgery has again been honored with the esteemed Mitral Valve Repair Reference Center Award from the American Heart Association and the Mitral Foundation for our second consecutive year. 
This recognition underscores our sustained leadership in mitral valve repair and our unwavering commitment to delivering exemplary cardiac care

Advocating for Surgical Aortic Valve Replacement: An Interview With Leonard N. Girardi, MD

Fascinating in-depth interview with Dr. Joel Dunning, Cardiothoracic Surgeon at James Cook University Hospital.

Dr. Leonard Girardi highlighting the efficacy and durability of Surgical Aortic Valve Replacement (SAVR). This was recently presented at 60th STS Annual meeting in San Antonio Texas "Drop the Wire, Pick Up the Knife: Bring SAVR Back!"

Dr. Girardi underscored the importance of putting patients first by ensuring clear communication on treatment options and post-surgical care.

Dr. Girardi with Dr. Joel Dunning

Less Invasive Early Lung Cancer Study Receives Top 10 Clinical Research Achievement Award

Nasser Altorki, MD

Dr. Nasser Altorki in OR

A Weill Cornell Medicine-led research team has been awarded a 2024 Top 10 Clinical Research Achievement Award from the Clinical Research Forum in recognition of an influential 2023 New England Journal of Medicine study on early-stage lung cancer resection.

The clinical trial results were published Feb. 9, 2023 by a team led by Dr. Nasser Altorki, chief of the Division of Thoracic Surgery in the Department of Cardiothoracic Surgery at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, and co-investigators from Duke University as well as investigators from 83 hospitals across the United States, Canada and Australia. The trial found that a surgery that removes only a portion of one of the five lobes that comprise a lung is as effective as removing an entire lobe for certain early-stage lung cancer patients.

Click here to learn more about the article

Up and-coming Bronchoscopic Ablation Therapies for Treatment of Lung Cancer

Click here to lean more about Dr. Ali and Dr. Musani's article

Robotic Bronchoscopy: A Major Advance in the Diagnosis and Treatment of Early-Stage Lung Cancer

Dr. Ali and Dr. Shostak

Robotic technology isn’t replacing doctors; 
it’s helping them do what they do more safely and with greater control and precision than anyone could have imagined a few short years ago.

“That’s why robotic bronchoscopy is such a game-changer,” Dr. Shostak continues. “It’s like a GPS system that gives us a virtual map telling us which way to turn next as we ‘drive’ through that maze of subdividing airways. And because the robot-assisted method allows us to travel deep into the lung and identify hard-to-reach, potentially cancerous nodules, we can perform biopsies with greater precision and lower complication rates than was previously possible. 

“Our ability to perform robotic bronchoscopy, biopsy and surgical removal of cancerous nodules in one procedure shortens the treatment time window from 90 to 25 days,” Dr. Ali says. “That’s a 3-fold decrease”—one that translates to earlier diagnosis and treatment and to significantly improved survival rates. 

Click here to learn more 

WCM's Updates in Interventional Pulmonology Symposium: The Era of Robotics

Click here for more details

Dr. Iosif Gulkarov Named Chief of Cardiothoracic Surgery at NewYork-Presbyterian Queens

Dr. Iosif M. Gulkarov

Iosif Gulkarov, M.D.

Dr. Iosif Gulkarov, a leading adult cardiac surgeon, has been appointed chief of cardiothoracic surgery at NewYork-Presbyterian Queens, effective Oct. 1. Dr. Gulkarov was also recruited to Weill Cornell Medicine as an associate professor of clinical cardiothoracic surgery.

Click here to learn more

Lung Cancer Health Fair November 4th

Lung Health Fair Flyer

Cardiac Surgeons Issue ‘Call to Action’ to Improve CABG Outcomes in Women

One trial that may close the research gap is ROMA-WomenMario Gaudino, MD, PhD (Weill Cornell Medicine, New York, NY), one of the principal investigators, said that while there are observational data to support multiarterial grafting over a single arterial graft, this is being put to the test in a randomized trial in the 4,000-patient ROMA trial. Moreover, it remains possible the treatment effect may vary by sex. However, with only a minority of female patients (approximately 15%), ROMA, which has completed enrollment, would be unable to detect meaningful differences between men and women.

Given that concern, investigators took advantage of existing site infrastructure and launched ROMA-Women. Speaking in the EACTS session, Gaudino provided an update on the trial’s progress, noting it recently gained support from the Global Cardiovascular Research Funding Forum, an international consortium of funders for investigator-led multinational trials. To date, the trial has enrolled more than 200 out of a planned 1,300 patients—not including the roughly 700 female participants in ROMA who will be rolled into ROMA-Women—since the trial launched 3 months ago.

That pace of enrollment is “better than expected,” said Gaudino. “If we keep this pace, we can make this impossible trial possible.”

Click here to learn more

Pulmonologists Diagnose a Rare Respiratory Condition and Save a Patient’s Life

Arlene Packles had a violent cough. It didn’t sound quite human. It was like a seal’s bark or a car engine in trouble. And a round of coughing could last for an entire hour. 

Packles’ illness began in 2020, just when the COVID-19 pandemic began its inexorable sweep across the country. A woman with a severe cough wasn’t unusual back then. The novel coronavirus—SARS-CoV-2—tended to push other respiratory conditions to the margins, at least at first. But there was another reason why it took a while for the 73-year-old from Bergen County, New Jersey, to find her way to a diagnosis

Tracheobronchomalacia (TBM) is under-recognized by the pulmonary community, says Dr. Eugene Shostak, an Assistant Professor of Interventional Pulmonology who co-directs Weill Cornell’s TBM program with Dr. Oliver Chow, an Assistant Attending Cardiothoracic Surgeon and Assistant Professor of Clinical Cardiothoracic Surgery at Weill Cornell Medicine. 

Click Here to learn more 

Weill Cornell Medicine Cardiothoracic Surgery 525 East 68th Street
Box 110
Suite M 404
New York, NY 10065 Directions
Phone: (212) 746-5166